Merck patents on HCV treatment found valid in Gilead dispute

Pharmacy Today, American Pharmacists Association, pharmacist.com-5 hours ago

Merck told a federal jury in San Jose, CA, on Tuesday it is seeking more than $2 billion in damages from Gilead Sciences after the jury upheld the validity of two .